Please assess the completion status of the following clinical trial:

Trial Title: Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~laboratories -and not subjects - will be randomized. All laboratories will start doing smears, when indicated by randomization, they will switch to Xpert MTB/Rif. There are no inclusion or exclusion criteria for the labs. Sputum specimens from non-diagnostic (follow up) patients, second samples for diagnostic tests, insufficient volume/visible blood specimens will be excluded from the Xpert testing.

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Xpert MTB/Rif (Type: EXPERIMENTAL): Sputum specimens arriving during intervention period will be submitted to this technology, a real-time automated polymerase chain reaction test
- Sputum smear (Type: ACTIVE_COMPARATOR): Sputum smears arriving in the laboratory during the observation period will be submitted to the classic routine smear staining

Based on this trial design, predict the completion outcome and termination type (if applicable).